About This Role:
The Executive Director, Immunology Early Development Strategy & External Innovation, is a senior scientific and development leader within the Immunology Development Unit, reporting directly to the Vice President, Head of Immunology Early Development Innovation and Strategy. The role serves as a close strategic partner and delegate to the Vice President, with accountability for a Immunology portfolio priorities spanning research-to-development transitions, early clinical development strategy, external innovation, and business development and venture investing assessments.
This leader will connect scientific insight, clinical development judgment, and enterprise strategy to help Biogen identify, shape, and advance differentiated opportunities for patients with immune-mediated diseases. The position is designed for an accomplished bridge builder who earns trust through expertise, judgment, clarity, and follow-through. Success will depend on the ability to align stakeholders, frame consequential choices, and enable cross-functional teams toward high-quality decisions and execution.
The role will work closely with Research, Biomarkers, Clinical Pharmacology, Regulatory, Biostatistics, Clinical Operations, Product Development & Commercialization, Global Commercial, Corporate Strategy, Business Development and External Innovation, and partner companies. Depending on portfolio needs, the Executive Director may lead selected programs or strategic initiatives from preclinical development through proof of biology or proof of concept and contribute to later-stage development planning.
What You’ll Do:
- Act as a senior advisor and delegate of the Head of Immunology Early Development Innovation and Strategy, helping shape and execute key portfolio, organizational, and external priorities in Immunology.
- Lead the strategy for critical research-to-development transitions, early development planning, and portfolio decisions across selected Immunology programs.
- Serve as the delegated clinical development leader for select programs and portfolio initiatives to accelerate value creation.
- Drive evaluation of external opportunities for the Immunology Development Unit, integrating scientific, clinical, strategic, and commercial perspectives into meaningful clinical development plans.
- Develop evidence-based recommendations for governance and investment decisions, helping senior leaders navigate uncertainty and complexity.
- Foster productive collaborations across Research, Development, Commercial, Corporate Strategy, Business Development, and external partners.
- Influence and align cross-functional stakeholders to translate strategy into decisive action and execution.
- Mentor colleagues and strengthen organizational capability through thought partnership, coaching, and leadership.
- Ensure all activities are conducted in accordance with applicable regulatory, quality, ethical, and compliance standards.
Who You Are:
You are a highly credible scientific and drug development leader who can move comfortably between deep scientific discussions on targets and biology, to clinical strategy across indications to portfolio choices and decision-making. You listen carefully, synthesize complex information quickly, and bring structure to uncertain or contested situations. Colleagues seek your perspective because your recommendations are rigorous, balanced, pragmatic, and clear. You create momentum by building shared understanding and commitment across organizational boundaries, not by relying on positional authority.
Required Skills:
- MD, MD/PhD, PhD, PharmD, or equivalent doctoral degree in a relevant biomedical discipline.
- At least 15 years in pharmaceutical or biotechnology drug development, with progressive leadership responsibilities in research, pharmacology, clinical development, portfolio strategy, or external innovation.
- 2-3 years of experience in pharma or biotech industry.
- Expertise in immunology and immune-mediated diseases, with experience spanning one or more areas such as rheumatology, dermatology, gastroenterology, allergy, inflammation, or related fields.
- Demonstrated experience with multiple therapeutic modalities and driving through key development milestones.
- Demonstrated success bridging discovery and translational science to clinical development, including leadership of research-to-development transitions and early development strategies through key value-inflection milestones.
- Experience evaluating external opportunities, including business development, licensing, partnerships, venture investments, or strategic collaborations.
- Strong understanding of the scientific, clinical, regulatory, and commercial factors that influence development and portfolio decisions.
- Demonstrated ability to influence stakeholders up and down the organization and lead across a complex matrixed environment.
- Exceptional strategic thinking, judgment, and problem-solving skills, with the ability to make high-quality recommendations and articulate trade-offs in the face of uncertainty.
- Excellent communication and executive presence, with the ability to distill complex issues into clear, decision-ready recommendations.
Preferred Skills:
- Recognized scientific or development leadership demonstrated through publications, presentations, patents, advisory roles, or equivalent accomplishments.
- Experience leading teams through important regulatory milestones in early development (e.g., pre-IND or CTA meetings, clinical hold resolution)
#LI-TD1
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about Biogen.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Skills Required
- MD, MD/PhD, PhD, PharmD, or equivalent doctoral degree in a relevant biomedical discipline
- At least 15 years of experience in pharmaceutical or biotechnology drug development with progressive leadership responsibilities
- 2-3 years of experience in the pharma or biotechnology industry
- Expertise in immunology and immune-mediated diseases, including relevant therapeutic areas such as rheumatology, dermatology, gastroenterology, allergy, or inflammation
- Experience with multiple therapeutic modalities and key development milestones
- Experience bridging discovery and translational science to clinical development, including research-to-development transitions and early development strategies
- Experience evaluating external opportunities, including business development, licensing, partnerships, venture investments, or strategic collaborations
- Strong understanding of scientific, clinical, regulatory, and commercial factors influencing development and portfolio decisions
- Ability to influence stakeholders and lead across complex matrixed environments
- Exceptional strategic thinking, judgment, problem-solving, and ability to make recommendations under uncertainty
- Excellent communication and executive presence, with ability to distill complex issues into clear recommendations
- Scientific or development leadership demonstrated through publications, presentations, patents, advisory roles, or equivalent accomplishments
- Experience leading teams through early-development regulatory milestones, such as pre-IND or CTA meetings and clinical hold resolution
Biogen Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Biogen and has not been reviewed or approved by Biogen.
-
Fair & Transparent Compensation — Pay is generally positioned as competitive and often perceived as fair across roles, with total compensation framed as strong when bonus and equity are included. Compensation sentiment is described as above-average overall, though it varies by function and business cycle.
-
Equity Value & Accessibility — Equity programs are repeatedly highlighted as a meaningful part of the total package, including stock programs and an employee stock purchase plan. Equity and bonus elements are portrayed as important contributors to feeling well rewarded beyond base pay.
-
Leave & Time Off Breadth — Time-off benefits are described as distinctive, including a year-end shutdown and a paid sabbatical after extended tenure. Vacation, holidays, sick time, and personal-significance days are also presented as supportive of work-life needs.
Biogen Insights
What We Do
Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Zug, Switzerland and we have world-class manufacturing facilities in North Carolina and Denmark. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries. For more information, please visit www.biogen.com. Follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
.png)







